Discrete choice experiments in health economics: past, present and future

V Soekhai, EW de Bekker-Grob, AR Ellis, CM Vass - Pharmacoeconomics, 2019 - Springer
Abstract Objectives Discrete choice experiments (DCEs) are increasingly advocated as a
way to quantify preferences for health. However, increasing support does not necessarily …

[HTML][HTML] Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review

V Soekhai, C Whichello, B Levitan, J Veldwijk… - Drug discovery today, 2019 - Elsevier
Highlights•Preference studies are becoming increasingly important within the medical
product decision-making context.•Currently, there is limited understanding of the range of …

[HTML][HTML] Being precise about precision medicine: what should value frameworks incorporate to address precision medicine? A report of the personalized precision …

E Faulkner, AP Holtorf, CY Liu, H Lin, E Biltaj, D Brixner… - Value in Health, 2020 - Elsevier
Precision medicine is a dynamic area embracing a diverse and increasing type of
approaches that allow the targeting of new medicines, screening programs or preventive …

[HTML][HTML] Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review

E van Overbeeke, C Whichello, R Janssens… - Drug discovery today, 2019 - Elsevier
Highlights•Use of patient preferences in decision making is limited but gaining
attention.•Some situations and decisions are more sensitive to patient preferences than …

Use of patient preference studies in HTA decision making: a NICE perspective

JC Bouvy, L Cowie, R Lovett, D Morrison… - The Patient-Patient …, 2020 - Springer
Patient preference studies could provide valuable insights to a National Institute for Health
and Care Excellence committee into the preferences patients have for different treatment …

Analysis of patient preferences in lung cancer–estimating acceptable tradeoffs between treatment benefit and side effects

EM Janssen, SM Dy, AS Meara… - Patient preference …, 2020 - Taylor & Francis
Objective Increased treatment options and longer survival for lung cancer have generated
increased interest in patient preferences. Previous studies of patient preferences in lung …

Design, conduct, and use of patient preference studies in the medical product life cycle: a multi-method study

E Van Overbeeke, R Janssens, C Whichello… - Frontiers in …, 2019 - frontiersin.org
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS)
should be designed and conducted to allow for inclusion of patient preferences in decision …

Use of patient preferences in health technology assessment: perspectives of Canadian, Belgian and German HTA representatives

E van Overbeeke, V Forrester, S Simoens… - The Patient-Patient …, 2021 - Springer
Objective Patient preferences can be informative for health technology assessment (HTA)
and payer decision making. However, applications may be different per country. The aim of …

[HTML][HTML] Leveraging the similarities between cost-effectiveness analysis and value-based healthcare

J Walraven, MS Jacobs, CA Uyl-de Groot - Value in Health, 2021 - Elsevier
Objectives This article aims to explore overlaps and differences between the emerging
concept of value-based healthcare (VBHC) and the established field of cost-effectiveness …

Patient preference studies during early drug development: aligning stakeholders to ensure development plans meet patient needs

NS Cook, J Cave, AP Holtorf - Frontiers in Medicine, 2019 - frontiersin.org
Although patient preferences have been studied broadly for marketed products or around
the time of submission to authorities and launch, patient preference studies have rarely been …